Research on high flux hemodialysis in treatment of severe renal failure
10.3969/J.ISSN.1672-8270.2015.01.036
- VernacularTitle:高通量血液透析治疗严重肾衰竭的研究
- Author:
Mingai SONG
;
Lingzhi YAN
;
Xiaoxue WANG
- Publication Type:Journal Article
- Keywords:
High flux hemodialysis;
Severe renal failure;
Blood lipid;
Plasma protein;
Inflammatory factor
- From:
China Medical Equipment
2015;(1):113-115,116
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To investigate the high flux hemodialysis (HFD) on the application effect of severe renal failure patients the level of inflammatory factors, blood lipid and protein. Methods:In 2012 January to 2013 December was performed in 80 patients with severe renal failure in the treatment of MHD, were randomly divided into two groups, study group 40 cases by high-throughput MHD treatment, 40 cases in the control group using conventional MHD treatment. Results: There was no significant difference in two groups before treatment of various inflammatory factors difference (P>0.05); after the treatment, two groups of patients with TNF- α, IL-6 and hs-CRP levels were significantly lower(t=14.138, t=5.891, t=11.093;P<0.01), and lower levels of TNF-α, IL-6 and hs-CRP levels than the control group after treatment, the study group, with statistical significance correlation between data comparison of difference (t=17.913, P<0.05). Comparison of the plasma protein levels had no significant difference between the two groups before treatment (P>0.05);after the treatment, patients in study group were TP, ALB andβ2-M compared with those before treatment were significantly improved, ALB of control group had obvious improvement than before treatment (P<0.05); improve study group for plasma proteins relevant indexes are the control group was significant (t=2.515, t=59.923, t=3.474, P<0.01). No significant differences between the level of each lipid index (P>0.05);after the treatment, patients in study group TC and TG compared with those before treatment were significantly improved after treatment, and compared with the control group index improved significantly (t=2.963, t=6.914; P<0.01). Conclusion:High throughput MHD therapy based on conventional MHD filtration of small molecular toxin traits on patients with severe renal failure, increase the filtration range, clear promote inflammatory molecules, plasma proteins, blood lipid molecules, such as in large molecules, so as to achieve a better therapeutic effect.
